← All candidates
40 insider filings on record.
40 filings on record.
SOPHSOPHiA GENETICS SA
NasdaqGS · Healthcare · $677.62M
$7.96
+1.27% · Sep 15
40 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 35 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$677.62M
Float
65.4M
77% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
7.9
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
35 more transactions on Pro →Context
Wall St
$9.75 avg target
+22.5% vs today · 4 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q2 '26−$0.20 act+$0.02
Q1 '26−$0.19 act+$0.05
Q4 '25−$0.17 act+$0.03
Q3 '25−$0.20 act+$0.00
Coverage
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance RaiseSimply Wall St. · 1w agoSOPHiA GENETICS (SOPH) Q2 2026 Earnings Call TranscriptMotley Fool · 08-11SOPHiA GENETICS partners with AstraZeneca for oncology diagnosticsMedical Device Network · 08-05Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ...GuruFocus.com · 08-04
The file stays open
40 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice